Investors rewarded Neurocrine Biosciences (NASDAQ: NBIX) on Wednesday for posting a Q1 of fiscal 2020 earnings report that featured encouraging growth in key financials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,